Xenitra (ASX:XEN)

ASX announcement history & article coverage

15
Total announcements
(in last 3 months)
4
With article
11
No article
Article coverage
27%
Transparent by design. Announcments by Xenitra (ASX:XEN) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

25 Sept 2026 · 05:05 pm AEST ASX Filing
Quoted Option Expiry
7 Sept 2026 · 06:51 pm AEST ASX Filing
Notice Under Section 708A
7 Sept 2026 · 06:49 pm AEST ASX Filing
Application for quotation of securities - XEN
1 Sept 2026 · 05:12 pm AEST ASX Filing
Notice Under Section 708A
1 Sept 2026 · 04:56 pm AEST ASX Filing
Application for quotation of securities - XEN

31 Aug 2026 · 06:44 pm AEST ASX Filing
Appendix 4G and Corporate Governance Statement
31 Aug 2026 · 05:50 pm AEST ⚡ Price SensitiveMaterial ASX Filing
Appendix 4E and Annual Report
Xenitra Limited reports strategic turnaround with revenue recovery, cost cuts, and new growth platforms; loss widens to $5.18 million
24 Aug 2026 · 09:57 am AEST ASX Filing
Proposed issue of securities - XEN
24 Aug 2026 · 09:57 am AEST ⚡ Price SensitiveMaterial ASX Filing
Xenitra Raises $1.5m to Accelerate High-Margin Sales Growth
Xenitra raises A$1.5 million placement to accelerate higher-margin sales growth across OTC, FSMP, and OPAL
20 Aug 2026 · 09:37 am AEST ⚡ Price Sensitive ASX Filing
Trading Halt
18 Aug 2026 · 09:47 am AEST ⚡ Price SensitiveMaterial ASX Filing
$5m Offtake Agreement Expands OTC-Medicine Business
Xenitra signs A$5 million three-year FSMP procurement agreement with Joy Charm

30 July 2026 · 11:24 am AEST ASX Filing
Investor Presentation
30 July 2026 · 08:30 am AEST ⚡ Price SensitiveMaterial ASX Filing
Quarterly Activities/Appendix 4C Cash Flow Report
Xenitra reports positive cash flow turnaround and strong growth in OTC and OPAL sales
28 July 2026 · 08:40 am AEST ASX Filing
Investor Webinar
27 July 2026 · 08:55 am AEST ⚡ Price SensitiveMaterial ASX Filing
$12M OFFTAKE AGREEMENT WITH LEADING OTC-PHARMACEUTICAL
Xenitra secures A$12 million OTC pharmaceutical procurement deal with Kangsheng in China